BG95330A - Контрастни средства - Google Patents

Контрастни средства

Info

Publication number
BG95330A
BG95330A BG095330A BG9533091A BG95330A BG 95330 A BG95330 A BG 95330A BG 095330 A BG095330 A BG 095330A BG 9533091 A BG9533091 A BG 9533091A BG 95330 A BG95330 A BG 95330A
Authority
BG
Bulgaria
Prior art keywords
contrast agents
ray
agent
contrast
ioverzole
Prior art date
Application number
BG095330A
Other languages
English (en)
Other versions
BG60951B1 (en
Inventor
Torsten Almen
Lars Baath
Audun Oksendal
Original Assignee
Nycomed Imaging A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging A/S filed Critical Nycomed Imaging A/S
Publication of BG95330A publication Critical patent/BG95330A/bg
Publication of BG60951B1 publication Critical patent/BG60951B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Liquid Crystal (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Lubricants (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Контрастните средства намират приложение в рентгеновата диагностика. То се състои от нейоногенен рентгенов контрастен агент във физиологично поносим воден носител, като концентрацията на натриевия йон е от 20 до 60 мм, а когато посоченият агент е йоверзол, концентрацията на йод е от 26 до 36 мм. 15 претенции
BG95330A 1989-03-17 1991-10-16 Contrast forms BG60951B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898906130A GB8906130D0 (en) 1989-03-17 1989-03-17 Compositions
PCT/EP1990/000393 WO1990011094A1 (en) 1989-03-17 1990-03-09 Contrast media

Publications (2)

Publication Number Publication Date
BG95330A true BG95330A (bg) 1993-12-24
BG60951B1 BG60951B1 (en) 1996-07-31

Family

ID=10653498

Family Applications (1)

Application Number Title Priority Date Filing Date
BG95330A BG60951B1 (en) 1989-03-17 1991-10-16 Contrast forms

Country Status (32)

Country Link
US (1) US5366722B1 (bg)
EP (2) EP0463013A1 (bg)
JP (1) JP2977045B2 (bg)
KR (1) KR920700701A (bg)
CN (1) CN1057703C (bg)
AT (1) ATE123954T1 (bg)
AU (1) AU638235B2 (bg)
BG (1) BG60951B1 (bg)
CA (1) CA2046886A1 (bg)
CZ (1) CZ281381B6 (bg)
DD (1) DD295992A5 (bg)
DE (1) DE69020208T2 (bg)
DK (1) DK0390242T3 (bg)
EG (1) EG19431A (bg)
ES (1) ES2073505T3 (bg)
FI (1) FI914337A7 (bg)
GB (1) GB8906130D0 (bg)
GR (1) GR3017133T3 (bg)
HU (1) HU206835B (bg)
IE (1) IE67885B1 (bg)
IL (1) IL93752A (bg)
JO (1) JO1619B1 (bg)
NO (1) NO302064B1 (bg)
NZ (1) NZ232954A (bg)
OA (1) OA09392A (bg)
PT (1) PT93471B (bg)
RO (1) RO112246B1 (bg)
RU (1) RU2088261C1 (bg)
TR (1) TR25111A (bg)
WO (1) WO1990011094A1 (bg)
YU (1) YU47911B (bg)
ZA (1) ZA902052B (bg)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919929D0 (en) * 1989-09-04 1989-10-18 Nycomed As Compositions
US5869024A (en) * 1989-11-29 1999-02-09 Bracco International B.V. Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures
US5614638A (en) * 1989-11-29 1997-03-25 Bracco International B.V. Nonionic radiographic contrast agents
RU2098131C1 (ru) 1990-03-09 1997-12-10 Нюкомед Имагинг А.С. Контрастная среда и способ ее получения
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
US5527926A (en) * 1990-11-26 1996-06-18 Bracco International B.V. Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures
US5278311A (en) * 1992-06-05 1994-01-11 E. R. Squibb & Sons, Inc. Nonionic radiographic contrast agents
IT1256248B (it) * 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
GB9419206D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
GB9419203D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
BR9707081A (pt) * 1996-01-25 1999-05-25 Schering Ag Soluções de injeção e infusão concentradas aperfeiçoadas para aplicação intravasal
EP0885616A1 (de) * 1997-06-20 1998-12-23 Schering Aktiengesellschaft Verwendung von intravenösen Kontrastmitteln sowie Vorrichtungen für die Projektionsmammographie
CN102596257B (zh) * 2009-10-29 2013-08-21 通用电气医疗集团股份有限公司 包含具有优良安全性概况的血浆阳离子的诊断组合物
AU2011231721B2 (en) * 2010-03-23 2014-08-14 Ge Healthcare As Preparation of stabilised X-ray diagnostic composition
KR20150134346A (ko) 2013-03-27 2015-12-01 지이 헬스케어 에이에스 진단 조성물을 제조하기 위한 방법 및 시약

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2909439A1 (de) * 1979-03-08 1980-09-18 Schering Ag Neue nichtionische roentgenkontrastmittel
DE2928417A1 (de) * 1979-07-12 1981-01-29 Schering Ag Trijodierte basen
DE3038853A1 (de) * 1980-10-10 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue n-hydroxy-alkylierte dicarbonsaeure-bis-(3,5-dicarbamoyl-2,4,6-trijodanilide), deren herstellung und diese enthaltende roentgenkonstrastmittel (ii)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
ATE72398T1 (de) * 1984-06-22 1992-02-15 Richard L Veech Polyanionische materialien enthaltende elektrolytloesungen.
CA1264442A (en) * 1984-06-22 1990-01-16 Richard L. Veech Electrolyte solutions and in vivo use thereof
US4863714A (en) * 1987-02-05 1989-09-05 Cook Imaging Corporation Sterilization of compositions of limited stability
US5011925A (en) * 1989-03-09 1991-04-30 Mallinckrodt, Inc. Morpholinoamido EDTA derivatives

Also Published As

Publication number Publication date
US5366722B1 (en) 2000-03-14
ES2073505T3 (es) 1995-08-16
ZA902052B (en) 1990-12-28
CA2046886A1 (en) 1990-09-18
FI914337A0 (fi) 1991-09-16
DD295992A5 (de) 1991-11-21
WO1990011094A1 (en) 1990-10-04
EP0390242A1 (en) 1990-10-03
EP0463013A1 (en) 1992-01-02
BG60951B1 (en) 1996-07-31
OA09392A (en) 1992-09-15
DK0390242T3 (da) 1995-08-14
IL93752A0 (en) 1990-12-23
IE67885B1 (en) 1996-05-01
EG19431A (en) 1995-10-31
NO302064B1 (no) 1998-01-19
IL93752A (en) 1994-11-11
CN1045528A (zh) 1990-09-26
JP2977045B2 (ja) 1999-11-10
JPH04504114A (ja) 1992-07-23
IE900970L (en) 1990-09-17
RO112246B1 (ro) 1997-07-30
CN1057703C (zh) 2000-10-25
RU2088261C1 (ru) 1997-08-27
KR920700701A (ko) 1992-08-10
AU5185490A (en) 1990-10-22
ATE123954T1 (de) 1995-07-15
GR3017133T3 (en) 1995-11-30
AU638235B2 (en) 1993-06-24
TR25111A (tr) 1992-11-01
FI914337A7 (fi) 1991-09-16
NZ232954A (en) 1992-04-28
PT93471A (pt) 1990-11-07
DE69020208T2 (de) 1996-03-21
NO913641D0 (no) 1991-09-16
DE69020208D1 (de) 1995-07-27
HUT59015A (en) 1992-04-28
YU47911B (sh) 1996-05-20
CZ281381B6 (cs) 1996-09-11
US5366722A (en) 1994-11-22
JO1619B1 (en) 1991-11-27
PT93471B (pt) 1996-03-29
NO913641L (no) 1991-09-16
EP0390242B1 (en) 1995-06-21
HU206835B (en) 1993-01-28
YU50390A (sh) 1994-01-20
GB8906130D0 (en) 1989-05-04
HU902356D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
DE68906153D1 (de) Humanes relaxinpraeparat.
IT8449184A1 (it) Agente attivo nel trattamento di tossicomania in particolare da eroina costituito da una composizione contenente ibogaina
FI920238A0 (fi) Varjoaineita
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
JPS5161620A (bg)
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
EP0165994A4 (en) CONTRAST AGENTS AND THEIR USE.
AU1446488A (en) 2-hydroxy-3-aminopropionic-n,n-diacetic acid and derivatives thereof, preparation thereof, and detergents containing same
ES2073505T3 (es) Medios de contraste.
ES2051461T3 (es) Medios de contraste.
ES8403623A1 (es) Procedimiento para la determinacion de bilirrubina directa y total en liquidos corporales.
ES2042532T3 (es) Procedimiento para preparar un agente destinado a la terapia o profilaxis de trastornos hemostaticos.
MY103079A (en) New ophtalmological composition of matter
FI905419A0 (fi) Icke-joniska roentgenkontrastmedel med hoeg jodhalt.
FI850644A7 (fi) Menettelytapa in vitro -taudinmäärityksessä ja taudinmääritysaine.
FR2458071A1 (bg)
ES2067052T3 (es) Procedimiento para el tratamiento final de tensioactivos anfoteros o zwitterionicos.
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
FI883988A7 (fi) Glysidoksipropyylisilanolin ja polydimetyylisiloksaanien käyttö ja niitä sisältävät vesipitoiset irrotusaineet.
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
PE43995A1 (es) Procedimiento para la prevencion de la degradacion de la proteina c
GR77250B (bg)
IT8721446A0 (it) Procedimento e dispositivo per la determinazione di agenti tensioattivi presenti in una soluzione acquosa.
ATE306914T1 (de) Wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie